Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis Model.

Journal article published in 2018 by Y. Li, Y. Xiong, G. Zhang, L. Zhang, W. Yang, J. Yang, L. Huang

, Z. Qiao, Z. Miao, G. Lin, Q. Sun, T. Niu, L. Chen, D. Niu, L. Li and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload